BFM
ARNA

Boothbay Fund Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Boothbay Fund Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,500
Closed -$232K – 2695
2021
Q4 		$232K Sell
2,500
-12,400
-83% -$817K 0.01% 1411
2021
Q3 		$887K Sell
14,900
-1,700
-10% -$100K 0.02% 825
2021
Q2 		$1.13M Buy
16,600
+16,434
+9,900% +$1.07M 0.04% 631
2021
Q1 		$1.15M Buy
166
+122
+277% +$9.39K 0.04% 525
2020
Q4 		$338K Sell
44
-239
-84% -$17.9K 0.01% 905
2020
Q3 		$2.12M Buy
+283
New +$18.9K 0.13% 210

Boothbay Fund Management's ARNA Position: Q4 2021 in Review

Boothbay Fund Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 4,730 shares — an estimated $312K sold.

Boothbay Fund Management first reported a position in ARNA in Q1 2018 and held it in 2 quarters. The position peaked at $282K in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Boothbay Fund Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 4,730 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $312K.
  • Boothbay Fund Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
  • Boothbay Fund Management's Arena Pharmaceuticals Inc position peaked at $282K in Q3 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.